vs
帕可Bio（PACB）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是帕可Bio的1.8倍（$78.6M vs $44.6M），帕可Bio净利率更高（-90.4% vs -178.3%，领先87.9%），帕可Bio同比增速更快（13.8% vs 0.4%），Repay Holdings Corp自由现金流更多（$23.2M vs $-19.9M），过去两年帕可Bio的营收复合增速更高（7.3% vs -1.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
PACB vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.8倍
$44.6M
营收增速更快
PACB
高出13.4%
0.4%
净利率更高
PACB
高出87.9%
-178.3%
自由现金流更多
RPAY
多$43.2M
$-19.9M
两年增速更快
PACB
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $78.6M |
| 净利润 | $-40.4M | $-140.1M |
| 毛利率 | 37.1% | 74.2% |
| 营业利润率 | -92.3% | -182.2% |
| 净利率 | -90.4% | -178.3% |
| 营收同比 | 13.8% | 0.4% |
| 净利润同比 | -1802.7% | -3304.1% |
| 每股收益（稀释后） | $-0.11 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBRPAY
| Q4 25 | $44.6M | $78.6M | ||
| Q3 25 | $38.4M | $77.7M | ||
| Q2 25 | $39.8M | $75.6M | ||
| Q1 25 | $37.2M | $77.3M | ||
| Q4 24 | $39.2M | $78.3M | ||
| Q3 24 | $40.0M | $79.1M | ||
| Q2 24 | $36.0M | $74.9M | ||
| Q1 24 | $38.8M | $80.7M |
净利润PACBRPAY
| Q4 25 | $-40.4M | $-140.1M | ||
| Q3 25 | $-38.0M | $-6.4M | ||
| Q2 25 | $-41.9M | $-102.3M | ||
| Q1 25 | $-426.1M | $-7.9M | ||
| Q4 24 | $2.4M | $-4.1M | ||
| Q3 24 | $-60.7M | $3.2M | ||
| Q2 24 | $-173.3M | $-4.1M | ||
| Q1 24 | $-78.2M | $-5.2M |
毛利率PACBRPAY
| Q4 25 | 37.1% | 74.2% | ||
| Q3 25 | 41.4% | 74.4% | ||
| Q2 25 | 36.9% | 75.7% | ||
| Q1 25 | -3.7% | 75.9% | ||
| Q4 24 | 25.6% | 76.3% | ||
| Q3 24 | 25.0% | 77.8% | ||
| Q2 24 | 16.5% | 78.2% | ||
| Q1 24 | 29.1% | 76.2% |
营业利润率PACBRPAY
| Q4 25 | -92.3% | -182.2% | ||
| Q3 25 | -101.1% | -3.9% | ||
| Q2 25 | -112.8% | -138.7% | ||
| Q1 25 | -1154.5% | -4.7% | ||
| Q4 24 | -390.1% | -1.5% | ||
| Q3 24 | -160.3% | -0.9% | ||
| Q2 24 | -488.3% | -4.6% | ||
| Q1 24 | -209.6% | -3.1% |
净利率PACBRPAY
| Q4 25 | -90.4% | -178.3% | ||
| Q3 25 | -98.9% | -8.3% | ||
| Q2 25 | -105.4% | -135.2% | ||
| Q1 25 | -1146.8% | -10.3% | ||
| Q4 24 | 6.0% | -5.3% | ||
| Q3 24 | -151.9% | 4.1% | ||
| Q2 24 | -481.3% | -5.4% | ||
| Q1 24 | -201.4% | -6.5% |
每股收益（稀释后）PACBRPAY
| Q4 25 | $-0.11 | $-1.68 | ||
| Q3 25 | $-0.13 | $-0.08 | ||
| Q2 25 | $-0.14 | $-1.15 | ||
| Q1 25 | $-1.44 | $-0.09 | ||
| Q4 24 | $-0.44 | $-0.04 | ||
| Q3 24 | $-0.22 | $0.03 | ||
| Q2 24 | $-0.64 | $-0.04 | ||
| Q1 24 | $-0.29 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $5.3M | $484.4M |
| 总资产 | $784.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资PACBRPAY
| Q4 25 | $279.5M | $115.7M | ||
| Q3 25 | $298.7M | $95.7M | ||
| Q2 25 | $314.7M | $162.6M | ||
| Q1 25 | $343.1M | $165.5M | ||
| Q4 24 | $389.9M | $189.5M | ||
| Q3 24 | $471.1M | $168.7M | ||
| Q2 24 | $509.8M | $147.1M | ||
| Q1 24 | $561.9M | $128.3M |
总债务PACBRPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益PACBRPAY
| Q4 25 | $5.3M | $484.4M | ||
| Q3 25 | $36.1M | $616.9M | ||
| Q2 25 | $61.5M | $633.7M | ||
| Q1 25 | $91.6M | $755.7M | ||
| Q4 24 | $506.6M | $761.3M | ||
| Q3 24 | $453.1M | $754.7M | ||
| Q2 24 | $492.7M | $815.4M | ||
| Q1 24 | $649.0M | $813.8M |
总资产PACBRPAY
| Q4 25 | $784.1M | $1.2B | ||
| Q3 25 | $803.2M | $1.3B | ||
| Q2 25 | $825.5M | $1.4B | ||
| Q1 25 | $860.8M | $1.5B | ||
| Q4 24 | $1.3B | $1.6B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.7B | $1.5B |
负债/权益比PACBRPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $23.2M |
| 自由现金流率自由现金流/营收 | -44.6% | 29.6% |
| 资本支出强度资本支出/营收 | 1.9% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $90.7M |
8季度趋势，按日历期对齐
经营现金流PACBRPAY
| Q4 25 | $-19.1M | $23.3M | ||
| Q3 25 | $-18.7M | $32.2M | ||
| Q2 25 | $-29.4M | $33.1M | ||
| Q1 25 | $-44.1M | $2.5M | ||
| Q4 24 | $-30.6M | $34.3M | ||
| Q3 24 | $-45.5M | $60.1M | ||
| Q2 24 | $-54.3M | $31.0M | ||
| Q1 24 | $-75.7M | $24.8M |
自由现金流PACBRPAY
| Q4 25 | $-19.9M | $23.2M | ||
| Q3 25 | $-18.8M | $32.1M | ||
| Q2 25 | $-29.9M | $33.0M | ||
| Q1 25 | $-45.4M | $2.4M | ||
| Q4 24 | $-32.3M | $34.0M | ||
| Q3 24 | $-46.3M | $59.8M | ||
| Q2 24 | $-55.7M | $30.5M | ||
| Q1 24 | $-79.6M | $24.7M |
自由现金流率PACBRPAY
| Q4 25 | -44.6% | 29.6% | ||
| Q3 25 | -48.9% | 41.3% | ||
| Q2 25 | -75.3% | 43.6% | ||
| Q1 25 | -122.3% | 3.0% | ||
| Q4 24 | -82.3% | 43.5% | ||
| Q3 24 | -115.7% | 75.6% | ||
| Q2 24 | -154.8% | 40.7% | ||
| Q1 24 | -205.0% | 30.6% |
资本支出强度PACBRPAY
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 0.2% | 0.2% | ||
| Q2 25 | 1.4% | 0.1% | ||
| Q1 25 | 3.7% | 0.2% | ||
| Q4 24 | 4.1% | 0.3% | ||
| Q3 24 | 2.0% | 0.3% | ||
| Q2 24 | 4.1% | 0.6% | ||
| Q1 24 | 10.0% | 0.1% |
现金转化率PACBRPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
